SPONTON, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 488
EU - Europa 256
AS - Asia 156
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 915
Nazione #
US - Stati Uniti d'America 485
SE - Svezia 87
CN - Cina 78
SG - Singapore 42
IE - Irlanda 30
FR - Francia 28
AT - Austria 22
FI - Finlandia 22
IT - Italia 19
DE - Germania 14
SN - Senegal 12
UA - Ucraina 10
IN - India 9
KR - Corea 9
VN - Vietnam 9
PL - Polonia 7
ES - Italia 6
CA - Canada 3
NL - Olanda 3
TW - Taiwan 3
GB - Regno Unito 2
HK - Hong Kong 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
CH - Svizzera 1
EC - Ecuador 1
EU - Europa 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
LU - Lussemburgo 1
LV - Lettonia 1
RO - Romania 1
TH - Thailandia 1
TN - Tunisia 1
Totale 915
Città #
Houston 60
Chandler 45
Beijing 41
Ashburn 40
Santa Clara 36
Singapore 36
Ann Arbor 31
Dublin 28
Fairfield 22
Nyköping 21
Vienna 21
Dearborn 14
Princeton 12
Wilmington 11
Menlo Park 10
Jacksonville 9
Villeurbanne 9
Torino 8
Fremont 7
Los Angeles 7
Medford 7
Alcobendas 6
Boston 6
Columbus 6
Dong Ket 6
Jinan 6
Seattle 6
Warsaw 6
Cambridge 5
Düsseldorf 5
Guangzhou 5
Washington 5
Boardman 4
Falls Church 4
Munich 4
Nanjing 4
Pisa 4
Pune 4
Wuhan 4
Amsterdam 3
Patna 3
Shanghai 3
Taipei 3
Woodbridge 3
Bardhaman 2
Chongqing 2
Cleveland 2
Norwalk 2
Redwood City 2
Toronto 2
Turin 2
Albuquerque 1
Alexandria 1
Athens 1
Atlanta 1
Baotou 1
Brussels 1
Darmstadt 1
Denver 1
Des Moines 1
Eau Claire 1
Farmington 1
Guayaquil 1
Hangzhou 1
Hefei 1
Jakarta 1
Jiaozuo 1
Kharkiv 1
Lansing 1
Lanuéjouls 1
Luxembourg 1
Milan 1
Moelndal 1
Montréal 1
Nanchang 1
Nanning 1
Napoli 1
Nonthaburi 1
North Charleston 1
Phoenix 1
Riga 1
Rome 1
Tampa 1
Tel Aviv 1
Verquières 1
Xian 1
Zurich 1
Totale 630
Nome #
Chimeric Rat/Human HER2 Efficiently Circumvents HER2 Tolerance in Cancer Patients. 196
Neutralization of IL-10 And TGF beta 1 rescues T cells from tolerogenic mechanisms induced by HER2 vaccine in cancer patients 123
DNA vaccines coding for chimeric human/rat HER2 as innovative immunotherapeutic tools for the treatment of HER2+ cancer patients 114
High Mobility Group Box 1 (hmgb1) Expands CD4+CD25+Foxp3+ T Cells and Increases the Expression of CD39 113
Dendritic cells transfected with ErbB-2 rat/human hybrid plasmid elicit an effective T cells response in ErbB-2+ cancer patients 96
Dendritic cells transfected with ErbB2 rat/human hybrid plasmid elicit an effective T cells response in ErbB2+ cancer patients 82
Dendritic cells transfected with DNA encoding ErbB2 rat/human chimeric plasmids are able to activate in vitro a specific T cell response in ErbB2+ cancer patients 81
Effective T cells response can be elicited in ErbB-2+ cancer patients by ErbB-2 rat/human hybrid plasmid transfection of dendritic cells 75
Erbb2 rat/human hybrid vaccine eludes self-antigen tolerance and elicits an effective t cells response in erbb2 cancer patients 70
Totale 950
Categoria #
all - tutte 2.772
article - articoli 0
book - libri 0
conference - conferenze 2.258
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.030


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202054 0 0 0 0 0 0 16 6 6 14 10 2
2020/202191 12 5 3 6 7 8 7 8 7 4 12 12
2021/2022139 1 2 1 12 13 7 13 12 2 20 41 15
2022/2023144 12 18 2 17 14 35 16 8 15 3 4 0
2023/202498 9 18 7 1 9 29 2 6 1 6 0 10
2024/2025113 0 9 9 11 60 24 0 0 0 0 0 0
Totale 950